MTOR and early-onset autosomal dominant Alzheimer disease: The mammalian target of rapamycin (mTOR) is a highly conserved serine-threonine kinase that is activated in response to various upstream signals such PI3K/Akt phosphorylation and mediates tau phosphorylation, representing a risk factor for Alzheimer's disease [176].